Health
Pepsodent launches oral hygiene awareness campaign in Malaysia
Targeting B40 communities, the initiative in partnership with MAHSA University's Faculty of Dentistry and MYDIN Prihatin will include distribution of 60,000 toothpaste kits worldwide KUALA LUMPUR, Malaysia, Oct. 23, 2023 /PRNewswire/ -- Pepsodent, a family-trusted, halal oral care brand tod...
2023-10-23 16:30
2033
Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001 Monotherapy Trial at the European Society for Medical Oncology Congress 2023
* HMBD-001 is Hummingbird Bioscience's proprietary anti-HER3 antibody in Phase I/IIa trials in the UK and Phase Ib trials inAustralia, targeting multiple solid tumors * The clinical data shows that HMBD-001 is safe and well-tolerated with no dose-limiting toxicities and no severe treatment-re...
2023-10-23 14:23
1667
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at JSA2023
TOKYO, Oct. 23, 2023 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (abbreviated as "Longbio Pharma"), a biotech company specializing in the development of treatments for allergy, asthma, nephrology, dermatology, ophthalmology and other autoimmune diseases, oral presented the phase I data of ...
2023-10-23 12:27
1919
EBR Systems nominated for MTAA Excellence in Medical Technology award
SUNNYVALE, Calif., Oct. 23, 2023 /PRNewswire/ -- EBR Systems, Inc. (ASX:EBR),
the developer of the world's only wireless cardiac pacing device for heart
failure, is pleased to announce it has been named as a nominee for the 2023
Medical Technology Association ofAustralia
2023-10-23 12:26
1814
Cancer Prevention Scholars and Climate Crisis Experts from Korea, US and Japan Come Together, iCOOP KOREA Holds the '2023 International Symposium'
SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- iCOOP KOREA held the
2023-10-23 07:00
2315
CPIC Life (H.K.) Assigned by Moody's An A3 IFSR, Outlook Stable
HONG KONG, Oct. 22, 2023 /PRNewswire/ -- China Pacific Life Insurance (H.K.)
Company Limited ("CPIC Life (HK)" or "the Company") is pleased to announce that
the Company was assigned byMoody's Investors Service
2023-10-22 11:09
2425
Gene Technology Light Up the Future - Opening of the International Conference of Genomics on Eye 2023
SHENYANG, China, Oct. 21, 2023 /PRNewswire/ -- The International Conference of Genomics on Eye 2023 (the "6th ICG Eye") embraced its grand opening in Shenyang on 14th-15th October. The conference, hosted by the Shenyang Municipal People's Government, organized by the Shenyang Bureau of Science a...
2023-10-21 03:12
3615
Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens
SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- On October 16th, the inaugural ceremony of the 2023 International Biopharma Industry Week Shanghai (IBIWS 2023) unfolded at the Zhangjiang Science Hall inShanghai. Spanning five days, this event, themed as "Striving Together for A Thriving Industry," endeav...
2023-10-20 15:29
2470
Europlasma NV has filed a lawsuit against Nanowatt BV
FUVEAU, France, Oct. 20, 2023 /PRNewswire/ -- Europlasma NV, a wholly-owned subsidiary of Plasmalex SAS, and a global technology leader in innovative nano-coating solutions based on low pressure plasma technology,has filed a lawsuit against Nanowatt BV as well as its Director Taco 12 BV (represen...
2023-10-20 08:00
2618
Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies
Wolters Kluwer uniquely leverages its expertise to meet market and customer needs, positioning it to capitalize on new growth opportunities and lead in healthcare conversational AI. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the conversational artificial inte...
2023-10-19 21:35
1716
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience's anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hummingbird Bioscience to receive upfront and milestone payments up to $430 million, plus royalties, from Endeavor BioMedicines Investigational New Drug ...
2023-10-19 20:18
1998
Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023
JINAN, China, Oct. 19, 2023 /PRNewswire/ -- Data from Qilu Pharmaceutical's clinical trial of its novel bifunctional antibody, QL1706 (iparomlimab and tuvonralimab), will be unveiled during a mini oral presentation at the European Society for Medical Oncology (ESMO) Annual Congress 2023. The ESMO...
2023-10-19 19:42
1936
PureSoftware Appoints Industry Veteran Steve Rosenberg as Board Advisor to Strengthen its Life Sciences and Healthcare Vertical
NEW YORK and NOIDA, India, Oct. 19, 2023 /PRNewswire/ -- PureSoftware, a global software and services provider, is proud to announce the appointment ofSteve Rosenberg, a distinguished leader in the Life Sciences and Healthcare technology industry, to its Advisory Board. With a career spanning ove...
2023-10-19 19:00
2180
ProstACT SELECT Study of TLX591 Interim Readout: Positive Results Confirm Safety and Tolerability
* The study has achieved its primary objectives, confirming the safety and tolerability profile of TLX591 administered in two doses, two weeks apart in combination with standard of care (SoC) * Preliminary activity demonstrates meaningful PSA[1] reduction; monitoring of patients is ongoing, i...
2023-10-19 06:01
1764
Dr. Huda Zoghbi Reveals New Research Into the Mechanisms Driving Rett Syndrome at the 2023 World Congress of Neurology
MONTREAL, Oct. 19, 2023 /PRNewswire/ -- Huda Zoghbi, MD, professor of molecular and human genetics,Baylor College of Medicine, has made a groundbreaking discovery in the field of neurology. Her research shows that mutations in the MECP2 gene are responsible for causing Rett syndrome, a childhood ...
2023-10-19 01:09
1655
Frost & Sullivan Recognizes Neuromod Devices with the 2023 New Product Innovation Award for Developing a Robust Solution That Meets Tinnitus Patients' Needs
Neuromod Devices uniquely leverages its sophisticated technology to meet tinnitus patients' dynamic needs and strict global regulatory requirements for medical devices. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the neuromodulation devices for tinnitus space ...
2023-10-19 01:03
1774
Driving Innovation in Diagnostics: Fapon's Latest Solutions at Indonesia Hospital Expo 2023
JAKARTA, Indonesia, Oct. 18, 2023 /PRNewswire/ -- Fapon, a leading life-science company, will showcase its latest innovations in IVD core raw materials, reagent services and open instrument platforms at Indonesia Hospital Expo 2023 fromOctober 18 to October 21, 2023. During the exhibition, the co...
2023-10-18 22:47
2457
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON and ROLLE, Switzerland, Oct. 18, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in da...
2023-10-18 20:00
1778
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
GAITHERSBURG, Md., Oct. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced thatSingapore's Health Sciences Authority (HSA) has granted full approval for Novavax's prototype COVID-19 vaccine Nuvaxovi...
2023-10-18 20:00
1581
Currax Pharmaceuticals: CONTRAVE®/MYSIMBA® demonstrates no increased risk in major adverse cardiac events in a large, long-term real-world evidence study
BRENTWOOD, Tenn., Oct. 18, 2023 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax") today announced top-line results from a Cardiovascular Health Outcomes Analysis (HOA). This study evaluated the cardiovascular safety of CONTRAVE®/MYSIMBA®, a weight management drug. The real-world study compare...
2023-10-18 20:00
1732
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Announcement of "Cyber Sousa Award" Winners of the 16th Xiamen International Animation Festival
[Picked up by 272 media titles]
2024-11-26 16:48
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12324
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
8375
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8090
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
7519
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
5841